Latest Insider Transactions at Liberty Latin America Ltd. (LILA)
This section provides a real-time view of insider transactions for Liberty Latin America Ltd. (LILA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Liberty Latin America Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Liberty Latin America Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,386
-2.55%
|
$11,088
$8.75 P/Share
|
|
Mar 01
2023
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,429
+4.28%
|
-
|
|
Mar 01
2023
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
678
-1.05%
|
$5,424
$8.75 P/Share
|
|
Mar 01
2023
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,990
+2.99%
|
-
|
|
Mar 01
2023
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-1.09%
|
$2,712
$8.75 P/Share
|
|
Mar 01
2023
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
995
+3.11%
|
-
|
|
Mar 01
2023
|
Balan Nair President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,507
-1.25%
|
$116,056
$8.75 P/Share
|
|
Mar 01
2023
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,105
+1.86%
|
-
|
|
Mar 01
2023
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,052
+1.64%
|
-
|
|
Mar 01
2023
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,549
-0.92%
|
$28,392
$8.75 P/Share
|
|
Mar 01
2023
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,315
+1.61%
|
-
|
|
Mar 01
2023
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,606
-1.11%
|
$12,848
$8.75 P/Share
|
|
Mar 01
2023
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,157
+2.14%
|
-
|
|
Jan 31
2023
|
Balan Nair President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
58,399
-4.86%
|
$525,591
$9.85 P/Share
|
|
Jan 31
2023
|
Balan Nair President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
139,543
+10.41%
|
-
|
|
Jan 31
2023
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
39,750
-9.46%
|
$357,750
$9.85 P/Share
|
|
Jan 31
2023
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
79,739
+15.95%
|
-
|
|
Jan 31
2023
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
15,288
-6.32%
|
$137,592
$9.85 P/Share
|
|
Jan 31
2023
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
30,669
+11.25%
|
-
|
|
Dec 31
2022
|
Rocio Lorenzo CCO |
BUY
Grant, award, or other acquisition
|
Direct |
473
+0.87%
|
$3,311
$7.6 P/Share
|
|
Dec 31
2022
|
Balan Nair President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
895
+0.08%
|
$6,265
$7.6 P/Share
|
|
Dec 31
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,220
+0.65%
|
$15,540
$7.6 P/Share
|
|
Dec 31
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
1,087
+0.51%
|
$7,609
$7.6 P/Share
|
|
Dec 31
2022
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
428
+0.14%
|
$2,996
$7.6 P/Share
|
|
Dec 31
2022
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
214
+0.14%
|
$1,498
$7.53 P/Share
|
|
Dec 31
2022
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,280
+0.12%
|
$15,960
$7.6 P/Share
|
|
Dec 31
2022
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,140
+0.18%
|
$7,980
$7.53 P/Share
|
|
Dec 31
2022
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,418
+3.98%
|
$16,926
$7.6 P/Share
|
|
Dec 31
2022
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,209
+4.6%
|
$8,463
$7.53 P/Share
|
|
Dec 31
2022
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,284
+4.25%
|
$15,988
$7.6 P/Share
|
|
Dec 31
2022
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+4.94%
|
$7,994
$7.53 P/Share
|
|
Dec 21
2022
|
Dustin Henderson |
BUY
Open market or private purchase
|
Direct |
100
+15.38%
|
$900
$9.47 P/Share
|
|
Dec 16
2022
|
Dustin Henderson |
BUY
Open market or private purchase
|
Direct |
100
+18.18%
|
$900
$9.5 P/Share
|
|
Dec 13
2022
|
Balan Nair President and CEO |
BUY
Open market or private purchase
|
Direct |
35,076
+3.2%
|
$245,532
$7.12 P/Share
|
|
Sep 30
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Other acquisition or disposition
|
Direct |
20,000
+50.0%
|
$120,000
$6.19 P/Share
|
|
Sep 30
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Other acquisition or disposition
|
Direct |
20,000
-12.38%
|
$120,000
$6.19 P/Share
|
|
Sep 30
2022
|
Balan Nair President and CEO |
SELL
Other acquisition or disposition
|
Direct |
20,000
-16.0%
|
$120,000
$6.19 P/Share
|
|
Sep 30
2022
|
Balan Nair President and CEO |
BUY
Other acquisition or disposition
|
Direct |
20,000
+2.98%
|
$120,000
$6.19 P/Share
|
|
Sep 30
2022
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,974
+0.16%
|
$17,844
$6.15 P/Share
|
|
Sep 30
2022
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,487
+0.24%
|
$8,922
$6.19 P/Share
|
|
Sep 30
2022
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,974
+5.05%
|
$17,844
$6.15 P/Share
|
|
Sep 30
2022
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,487
+5.87%
|
$8,922
$6.19 P/Share
|
|
Sep 30
2022
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
526
+0.18%
|
$3,156
$6.15 P/Share
|
|
Sep 30
2022
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
263
+0.18%
|
$1,578
$6.19 P/Share
|
|
Sep 30
2022
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,974
+5.7%
|
$17,844
$6.15 P/Share
|
|
Sep 30
2022
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,487
+6.67%
|
$8,922
$6.19 P/Share
|
|
Sep 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,512
-5.32%
|
$21,072
$6.62 P/Share
|
|
Sep 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,152
+15.54%
|
-
|
|
Sep 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,683
-5.3%
|
$10,098
$6.62 P/Share
|
|
Sep 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,823
+15.5%
|
-
|